ALX Oncology Holdings Inc. (ALXO) Tops Q3 EPS by 20c
Tweet
Share
E-mail
Get Alerts ALXO Hot Sheet
Join SI Premium – FREE
ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.58), $0.20 better than the analyst estimate of ($0.78).
For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- TSS, Inc. (TSSI) Misses Q2 EPS by 1c
- QXO, Inc. (QXO) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
